Litigation Details for MITSUBISHI TANABE PHARMA CORPORATION v. AUROBINDO PHARMA USA, INC. (D.N.J. 2020)
✉ Email this page to a colleague
MITSUBISHI TANABE PHARMA CORPORATION v. AUROBINDO PHARMA USA, INC. (D.N.J. 2020)
| Docket | ⤷ Sign Up | Date Filed | 2020-03-20 |
| Court | District Court, D. New Jersey | Date Terminated | 2020-07-17 |
| Cause | 15:1126 Patent Infringement | Assigned To | Renee Marie Bumb |
| Jury Demand | None | Referred To | Joel Schneider |
| Patents | 7,943,582; 8,513,202 | ||
| Link to Docket | External link to docket | ||
Details for MITSUBISHI TANABE PHARMA CORPORATION v. AUROBINDO PHARMA USA, INC. (D.N.J. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2020-03-20 | 1 | Complaint | United States Patent Nos. 7,943,582 (the “’582 patent”) and 8,513,202 (the “’202 patent”) (collectively… Infringement of U.S. Patent No. 7,943,582 by Aurobindo 31. Plaintiffs…collectively, the “Patents-in- Suit”) under the patent laws of the United States, 35 U.S.C. §100, et seq. This… THE PATENTS-IN-SUIT 8. On May 17, 2011, the United States Patent and Trademark… the ’582 patent. 10. JNV is an exclusive sublicensee of the ’582 patent. | External link to document |
| 2020-07-17 | 9 | Judgment - Consent | United States Patent Nos. 7,943,582 (“the ’582 Patent”) and 8,513,202 (“the ’202 Patent”); …expiration of the ’582 and ’202 Patents was a technical act of patent infringement with respect to one…expiration of the ’582 and ’202 Patents was a technical act of patent infringement with respect to one…the expiration of the ’582 and ’202 Patents, including any patent term extensions …States or with respect to any patent other than the ’582 and ’202 Patents. 7. All affirmative | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
